RH enters its September 10 earnings window carrying a bruising week — shares fell 17% to $141.30, extending a one-month slide of 19%, and the stock is doing it with over a quarter of its free float still in short hands.
The short interest story is the defining tension here. At 26.3% of free float, the short base is large by almost any measure. But the direction has shifted: short interest has declined 18% over the past month, from roughly 6 million shares in mid-July to just under 4.94 million now. That's a meaningful cover, not a rout — shorts have trimmed, but they haven't left. What makes this week's price action particularly sharp is that it happened while shorts were exiting. A 17% drop with the short base shrinking points to a selling wave driven by long holders, not fresh conviction from bears.
The lending market tells a quieter story. Availability has actually loosened considerably — nearly 182% of short interest is currently available to borrow, up from around 152% a week ago and well above the 52-week tightest reading of 73%. That's a comfortable pool for anyone looking to initiate or add to a short position. Borrowing costs remain negligible at 0.53%, barely changed over the month. This is not a lending market under stress; new shorts face no friction in getting set. The options market adds little to the tension — the put/call ratio at 0.84 is running a touch below its 20-day average of 0.86, about one standard deviation light on put demand. For a stock that just fell 17% in a week, options positioning looks almost relaxed.
The Street is split in a way that mirrors the broader uncertainty. JP Morgan maintained its Overweight rating but trimmed its target from $225 to $212 on August 17, still implying more than 50% upside from current levels — a target that looks ambitious with the stock at $141. Wells Fargo moved the other direction the week prior, raising its Overweight target from $175 to $225. Against those bulls, B of A Securities reinstated coverage earlier this month with an Underperform and a $156 target, suggesting limited upside even after the recent drawdown. Goldman Sachs upgraded to Neutral from Sell in July, lifting its target to $155 — close to where the stock is now. The consensus mean target of around $178 implies roughly 26% upside, but the dispersion between the $130 Stifel Hold and the $225 Wells Fargo Overweight reflects genuine disagreement about the pace of recovery. The bull case rests on RH Estates as a growth catalyst and an EBITDA margin target of 25–28%; the bear case points to housing market pressure, vendor risk, and execution uncertainty around new product rollouts. The ORTEX short score sits at 69.6 — well above the midpoint — with the company ranking in just the 7th percentile on short score relative to sector peers, underlining that this remains a stock where short-side positioning is structurally elevated.
The institutional picture adds one notable wrinkle. CEO and Chairman Gary Friedman sold approximately 48,000 shares across multiple transactions on July 8, collecting roughly $6.7 million, at prices between $155 and $161 — meaningfully above current levels. BlackRock built its position sharply over the same period, adding more than 580,000 shares through July 31, becoming a 10.5% holder. That's a split signal: the founder and public face of the brand reducing exposure, while a major index-weight manager adds. Friedman still holds 17% of shares outstanding, so the sale represents a modest trim rather than a strategic exit, but the timing — near what proved to be a local high — will draw scrutiny heading into earnings.
The next scheduled catalyst is the September 10 earnings print. The last quarterly release in June produced a mild positive reaction — the stock gained roughly 3% the following day before drifting flat over the subsequent week. The debate heading in is less about whether RH is growing and more about whether it can defend margins against tariff headwinds and articulate a credible acceleration timeline for RH Estates, with the short base and peer weakness from ARHS (down 11% on the week) adding to the cautious backdrop.
See the live data behind this article on ORTEX.
Open RH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
